Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 5Gastrointestinal 1

Conditions

Pancreatic Neoplasms 2Colorectal Neoplasms 2Tumor Virus Infections 1Recurrence 1Neoplasms 1Neoplasm Metastasis 1HIV Infections 1Anus Neoplasms 1Acquired Immunodeficiency Syndrome 1AIDS-Related Complex 1

Interventions

Specimen Handling 4Magnetic Resonance Spectroscopy 4Nivolumab 3Watchful Waiting 2Light Coagulation 2Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 2Fluorouracil 2Biopsy 2pembrolizumab 1dehydroftorafur 1cabozantinib 1Vorinostat 1Taxes 1Sigmoidoscopy 1Sentinel Lymph Node Biopsy 1Raltegravir Potassium 1Radiotherapy, Intensity-Modulated 1Proctoscopy 1Papanicolaou Test 1Paclitaxel 1Observation 1Mitozytrex 1Mitomycin 1Mass Screening 1Laser Therapy 1Isotretinoin 1Ipilimumab 1Interferon alpha-2 1Imiquimod 1Fluorodeoxyglucose F18 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
HIV Infections × Interferon alpha-2 × Gastrointestinal × Clear all
NCT00000764 2021-10-28

Chemoprevention of Anal Neoplasia Arising Secondary to Anogenital Human Papillomavirus Infection in Persons With HIV Infection.

National Institute of Allergy and Infectious Diseases (NIAID)

Phase 1 Completed
98 enrolled
Gastrointestinal

Acquired Immunodeficiency Syndrome, AIDS-Related Complex, Anus Neoplasms, Tumor Virus Infections, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡